Based on available evidence, the WHO guidelines provide strong recommendations for systematic screening, using both interferon-gamma releasing assays (IGRA) and tuberculin skin tests (TSTs), and treatment of household contacts of TB cases in all settings regardless of TB incidence and/or resources availability emphasising the benefits of early detection and treatment of TBI to prevent the spread of TB within households and communities.7 The gene discussed is IFNG; the disease is tuberculosis.